IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is a Healthcare company (Biotechnology) with a market capitalization of $3.1B. The Maz Rating grades it against the other companies in its sector.
IDEAYA Biosciences, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $31.83, IDEAYA Biosciences, Inc. trades at 84.2x sales and 3.0x book value. Over the last twelve months it generated about $37M of revenue and a net loss of $434M. It runs an operating margin of -1267.4% and a net margin of -1149.6%. It shows return on equity of -39.5%, return on invested capital of -41.3% and a free cash flow yield of -11.4%. On the balance sheet: a debt-to-equity ratio of 0.03 and a current ratio of 9.04. Over the past 52 weeks the share price ranged from $26.81 to $42.68, with a beta of -0.09.
IDEAYA Biosciences, Inc. does not currently pay a dividend.
26 Wall Street analyst ratings cover the stock: 24 Buy and 2 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.